JPRN-UMIN000043975
Completed
未知
A registry study on the usefulness of symptom monitoring by ePRO, and status of adverse events and QoL in cancer practice - RegiPRO study
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Esophageal cancer, gastric cancer, duodenal cancer, colon cancer, pancreatic cancer, cholangiocarcinoma, soft tissue tumor, GIST, neuroendocrine tumor, neuroendocrine cancer, malignant mesoderma, NSCLC, SCLC, breast cancer, etc.
- Sponsor
- St.Marianna University School of Medicine
- Enrollment
- 400
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients who find it clearly difficult to input using a touch screen electronic device (with or without assistance from family members, staff, etc.) 2\. Patients whose symptom evaluation is clearly difficult due to mental illness or cognitive impairment 3\. Participating in other PRO studies that burden ePRO input in this study at the same time 4\. Others that the principal investigator deems inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study evaluating Symptom and Distress screening tools in initiating early supportive care in cancer patients treated with curative radiation therapyHealth Condition 1: C00-D49- NeoplasmsCTRI/2022/01/039478Debnarayan Dutta
Recruiting
Not Applicable
The effect of voice therapy in improving voice quality in teachersMuscle tension dysphonia.Other voice and resonance disordersIRCT20170922036319N2Tehran University of Medical Sciences24
Recruiting
Not Applicable
Registry Study for Symptom Management and Monitoring By PHR APP in Routine Cancer Care PracticeCancerJPRN-UMIN000051589ational Cancer Center5,000
Completed
Not Applicable
A randomised pilot study of symptom-driven versus routine follow-up in asymptomatic breast cancer patients receiving regular mammographyBreast cancerCancerBreastISRCTN43743674International Collaborative Cancer Group (ICGG) (UK)
Recruiting
Not Applicable
An Observational Study of Follow-up for Symptomatic Adverse Events Using ePRO in Gastrointestinal Cancer Patients after Starting Oral Anticancer Therapy in Pharmacycolon cancer, gastric cancer, pancreas cancer, biliary tract cancerJPRN-UMIN000046186Hachioji Pharmaceutical Center Pharmacy77